142 related articles for article (PubMed ID: 25124617)
1. Expression of neuronal markers, NFP and GFAP, in malignant astrocytoma.
Hashemi F; Naderian M; Kadivar M; Nilipour Y; Gheytanchi E
Asian Pac J Cancer Prev; 2014; 15(15):6315-9. PubMed ID: 25124617
[TBL] [Abstract][Full Text] [Related]
2. Expression of diagnostic neuronal markers and outcome in glioblastoma.
Donev K; Scheithauer BW; Rodriguez FJ; Jenkins S
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):411-21. PubMed ID: 20298476
[TBL] [Abstract][Full Text] [Related]
3. Expression and Prognostic Value of Oct-4 in Astrocytic Brain Tumors.
Krogh Petersen J; Jensen P; Dahl Sørensen M; Winther Kristensen B
PLoS One; 2016; 11(12):e0169129. PubMed ID: 28030635
[TBL] [Abstract][Full Text] [Related]
4. New variants of malignant glioneuronal tumors: a clinicopathological study of 40 cases.
Varlet P; Soni D; Miquel C; Roux FX; Meder JF; Chneiweiss H; Daumas-Duport C
Neurosurgery; 2004 Dec; 55(6):1377-91: discussion 1391-2. PubMed ID: 15574220
[TBL] [Abstract][Full Text] [Related]
5. Neuronal immunoexpression and a distinct subtype of adult primary supratentorial glioblastoma with a better prognosis.
Pallud J; Dezamis E; Audureau E; Devaux B; Souillard-Scemama R; Sanai N; Page P; Beuvon F; Koziak M; Oppenheim C; Dhermain F; Schlienger M; Meder JF; Roux FX; Varlet P
J Neurosurg; 2012 Sep; 117(3):476-85. PubMed ID: 22725988
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathological study on malignant glioma--with special reference to GFAP].
Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
[TBL] [Abstract][Full Text] [Related]
7. Clinico-pathological analysis of pilocytic astrocytomas and gangliogliomas.
Fiks T; Jesionek-Kupnicka D; Zakrzewski K; Polis L; Liberski PP
Pol J Pathol; 2001; 52(1-2):47-51. PubMed ID: 11505680
[TBL] [Abstract][Full Text] [Related]
8. Pathologic analysis of primary brain tumors.
McComb RD; Burger PC
Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
[TBL] [Abstract][Full Text] [Related]
9. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
10. Morphometrical analysis of GFAP-positive cells in human astrocytomas.
Yoshii Y; Narushima K; Tsurushima H; Yanaka K; Hyodo A; Nose T; Sugiyama K; Sakamura S
Neurol Med Chir (Tokyo); 1992 Jul; 32(8):554-8. PubMed ID: 1383844
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of peroxiredoxin 1, peroxiredoxin 6 and GFAP in human brain astrocytoma and their clinical significance].
Zhou J; Liu Q; Wang J; Guo X; Song L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1255-9. PubMed ID: 22985558
[TBL] [Abstract][Full Text] [Related]
12. Divergent differentiation in pleomorphic xanthoastrocytoma. Evidence for a neuronal element and possible relationship to ganglion cell tumors.
Powell SZ; Yachnis AT; Rorke LB; Rojiani AM; Eskin TA
Am J Surg Pathol; 1996 Jan; 20(1):80-5. PubMed ID: 8540612
[TBL] [Abstract][Full Text] [Related]
13. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.
Nduom EK; Yang C; Merrill MJ; Zhuang Z; Lonser RR
J Neurosurg; 2013 Aug; 119(2):427-33. PubMed ID: 23621605
[TBL] [Abstract][Full Text] [Related]
15. A histopathological diagnostic marker for human spinal astrocytoma: expression of glial fibrillary acidic protein-δ.
Heo DH; Kim SH; Yang KM; Cho YJ; Kim KN; Yoon DH; Kang TC
J Neurooncol; 2012 May; 108(1):45-52. PubMed ID: 22318658
[TBL] [Abstract][Full Text] [Related]
16. Morphological appearance, growth kinetics and glial fibrillary acidic protein (GFAP) expression in primary in vitro explant culture of astrocytic neoplasms.
Kharbanda K; Sarkar C; Dinda AK; Karak AK; Mathur M; Roy S
Acta Oncol; 1993; 32(3):301-6. PubMed ID: 8391834
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of glial fibrillary acidic protein in avian sarcoma virus-induced gliomas in dogs.
Britt RH; Lyons BE; Eng LF; Bigner SH; Bigner DD
J Neurooncol; 1985; 3(1):53-9. PubMed ID: 2987428
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic xanthoastrocytoma - a clinico-pathological review.
Sharma A; Nand Sharma D; Kumar Julka P; Kishor Rath G
Neurol Neurochir Pol; 2011; 45(4):379-86. PubMed ID: 22101999
[TBL] [Abstract][Full Text] [Related]
19. Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.
Higuchi M; Ohnishi T; Arita N; Hiraga S; Hayakawa T
Acta Neuropathol; 1993; 85(5):481-7. PubMed ID: 7684178
[TBL] [Abstract][Full Text] [Related]
20. [Significance of immunohistochemistry in neuro-oncology. I. Demonstration of glial fibrillary acid protein (GFAP) in extracranial metastases from primary brain tumors].
Gottschalk J; Martin H; Kretschmer B; Barz H; Janda J; Szymas J
Zentralbl Allg Pathol; 1985; 130(5):391-6. PubMed ID: 3913231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
